270 Participants NeededMy employer runs this trial
Neridronate for Complex Regional Pain Syndrome
(CRPS-RISE Trial)
Recruiting at 5 trial locations
SC
Overseen BySVP, Clinical Operations
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Ambros Therapeutics, Inc.
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
What You Need to Know Before You Apply
What is the purpose of this trial?
Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
Are You a Good Fit for This Trial?
Inclusion Criteria
My CRPS symptoms started within the last 6 months.
Increased uptake in the involved limb compared to the contralateral limb on TPBS during Screening
I am 18 years old or older.
See 4 more
Exclusion Criteria
Significant dental findings such as an unhealed tooth extraction site
Hypocalcemia
Vitamin D deficiency
See 9 more
What Are the Treatments Tested in This Trial?
Interventions
- Neridronate
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Group I: neridronateExperimental Treatment1 Intervention
400 mg AMBTX-01 infusion
Group II: PlaceboPlacebo Group1 Intervention
Placebo comparator
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ambros Therapeutics, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.